Decompression Sickness Type II

Comprehensive Clinical Guide: Decompression Sickness Type II (DCS II)

Decompression Sickness (DCS), often colloquially termed "the bends," represents a systemic pathological condition resulting from the formation of inert gas bubbles (primarily nitrogen) within the blood and tissues. While Type I DCS is characterized by relatively localized, non-life-threatening manifestations (musculoskeletal pain, cutaneous involvement), Type II Decompression Sickness is a medical emergency involving the central nervous system (CNS), the cardiopulmonary system, or the inner ear. It represents a systemic insult that requires immediate hyperbaric intervention to prevent permanent neurological sequelae or mortality.

1. Etiology and Pathophysiology: The Mechanics of Bubble Formation

The fundamental driver of DCS II is the transition of inert gases—dissolved in tissues under high ambient pressure—into a gaseous phase during rapid decompression (ascent).

The Physical Mechanism

As a diver or high-altitude aviator ascends, the ambient pressure decreases. According to Henry’s Law, the amount of dissolved gas in a liquid is proportional to the partial pressure of that gas. When the ascent rate exceeds the body’s ability to eliminate nitrogen through pulmonary ventilation, supersaturation occurs, leading to the nucleation of bubbles.

Pathophysiological Cascade

DCS II is not merely a mechanical obstruction; it is a complex biochemical injury:
* Mechanical Obstruction: Bubbles act as emboli, blocking microvascular perfusion in the spinal cord, brain, and vestibular apparatus.
* Endothelial Activation: Bubbles act as foreign surfaces, triggering the activation of the complement system, platelets, and leukocytes.
* Inflammatory Response: The damaged endothelium releases inflammatory mediators, leading to plasma leakage, hemoconcentration, and secondary tissue ischemia.
* Spinal Cord Vulnerability: The spinal cord is the most frequent site of DCS II due to the low blood flow in the venous plexus and the high lipid content (which has a high affinity for nitrogen) of the myelin sheath.

2. Clinical Staging and Presentation

DCS II is categorized by the organ system involved. Clinical presentation is often rapid, occurring within 1–6 hours post-ascent, though delayed onset is possible.

Clinical Classification Table

The "Chokes" (Pulmonary DCS)

This is an ominous manifestation caused by massive venous gas emboli overwhelming the pulmonary capillary bed. It results in pulmonary hypertension, right-sided heart strain, and impaired gas exchange.

3. Diagnostic Protocols and Differential Diagnosis

Diagnosing DCS II is primarily clinical. There are no pathognomonic laboratory tests, but diagnostic imaging is used to rule out mimics.

Key Diagnostic Tests

1. Neurological Examination: A baseline assessment of cranial nerves, motor strength, sensory pathways, and cerebellar function is mandatory.
2. MRI (Brain/Spine): While often normal in the acute phase, it is vital for identifying spinal cord infarcts or intracranial hemorrhages.
3. Chest Radiography: Used to rule out pneumothorax or pulmonary edema.
4. Echocardiography: Useful for detecting a Patent Foramen Ovale (PFO), which acts as a shunt allowing venous bubbles to enter the arterial circulation (Paradoxical Embolism).

Differential Diagnosis

Clinicians must distinguish DCS II from:
* Arterial Gas Embolism (AGE): Often occurs immediately upon surfacing; usually presents with rapid-onset stroke-like symptoms.
* Ischemic Stroke: Sudden onset, usually unilateral.
* Spinal Cord Trauma: History of mechanical injury.
* Inner Ear Barotrauma: Usually occurs during descent (squeeze) rather than ascent.

4. Management and Treatment Modalities

The definitive treatment for DCS II is Hyperbaric Oxygen Therapy (HBOT).

Immediate Pre-Hospital Care

• 100% Normobaric Oxygen: Administer via a non-rebreather mask to facilitate nitrogen washout.
• Fluid Resuscitation: Isotonic crystalloids to maintain intravascular volume and improve microcirculatory flow.
• Positioning: Keep the patient supine to maintain cerebral perfusion.
• Evacuation: Immediate transport to the nearest hyperbaric facility (US Navy Treatment Table 6 is the gold standard).

HBOT Mechanism of Action

• Mechanical: Pressure reduction causes bubble shrinkage (Boyle’s Law).
• Physiological: High partial pressure of oxygen creates a diffusion gradient that accelerates the removal of nitrogen from the bubbles.
• Anti-inflammatory: HBOT inhibits leukocyte adhesion and reduces reperfusion injury.

5. Prognosis and Long-Term Sequelae

The prognosis for DCS II is highly dependent on the "time-to-treatment" interval.
* Full Recovery: Achievable in ~70-80% of cases if hyperbaric treatment is initiated within 6 hours.
* Residual Deficits: Chronic neurological impairment, including gait disturbances, bladder dysfunction, or cognitive slowing, may persist if treatment is delayed.
* Psychological Impact: Post-traumatic stress and anxiety regarding future diving are common.

6. Massive FAQ Section: Frequently Asked Questions

Q1: Is DCS II always fatal if untreated?

Not necessarily fatal, but the risk of permanent, life-altering neurological disability is extremely high. "Chokes" (pulmonary DCS) can lead to rapid respiratory failure and death.

Q2: Can I treat DCS II with aspirin?

Aspirin (325mg) is often recommended as an adjunct therapy to reduce platelet aggregation and inflammation, provided there are no contraindications (e.g., active bleeding).

Q3: How long does a hyperbaric session last?

A standard US Navy Treatment Table 6 lasts approximately 4 hours and 45 minutes, though it may be extended if symptoms persist.

Q4: Does a Patent Foramen Ovale (PFO) guarantee DCS II?

No. A PFO is a risk factor, not a cause. It allows venous bubbles to bypass the "pulmonary filter," increasing the risk of neurological DCS.

Q5: Can DCS II symptoms appear days later?

It is rare. Most symptoms appear within 24 hours. If symptoms appear after 48 hours, consider other neurological conditions.

Q6: What is the difference between DCS II and AGE?

AGE is the result of lung over-expansion (barotrauma) allowing air into the arteries. DCS II is the result of nitrogen coming out of solution. Both are treated with HBOT.

Q7: Are there any contraindications for HBOT?

Untreated pneumothorax is a strict contraindication and must be treated with a chest tube prior to hyperbaric compression.

Q8: Will I ever be able to dive again?

This requires a formal evaluation by a diving medicine specialist. Often, if there was significant neurological involvement, permanent medical disqualification from diving is recommended.

Q9: Does hydration prevent DCS II?

Adequate hydration maintains plasma volume, which supports microcirculatory perfusion and reduces the propensity for bubble formation. It is a critical preventive measure.

Q10: Is "the bends" just pain?

No. "Bends" usually refers to Type I (joint pain). Type II is systemic and involves organ systems; it is far more dangerous than simple joint pain.

7. Summary and Clinical Recommendations

For the medical professional, the priority in DCS II is early recognition and rapid recompression. Do not delay transport for diagnostic imaging if a hyperbaric chamber is available. The clinical mantra remains: "When in doubt, recompress."

Clinical Checklist for Practitioners:

1. Assess ABCs (Airway, Breathing, Circulation).
2. Administer 100% O2 immediately.
3. Perform neurological exam (Document deficits).
4. Communicate with the nearest Hyperbaric Physician/Diving Medical Officer.
5. Monitor for secondary complications such as aspiration or cardiac arrhythmia.

By strictly adhering to decompression algorithms and maintaining a high index of suspicion for atypical neurological or cardiopulmonary presentations, the morbidity associated with DCS II can be significantly mitigated. This guide serves as a baseline for clinical decision-making, emphasizing that DCS II is a time-sensitive emergency where clinical outcomes are directly proportional to the speed of professional intervention.